Infusion of Apomorphine: Long-term Safety Study

NCT02339064 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Parkinson's Disease

Interventions

DRUG: apomorphine infusion

Sponsor

MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals